MELVIN CHAN: Open Payments
NPI 1508271313 · BELLE MEAD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$185 in 8 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $185
Food & beverage: $185
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 2 | $59 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| ABBVIE INC. | 1 | $27 |
| Celltrion USA Inc. | 1 | $24 |
| Incyte Corporation | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
Products named: IBRANCE, EPKINLY, VEGZELMA, ADCETRIS, JAKAFI, CALQUENCE, NINLARO.
Industry payments across NJ — which companies pay providers there.
